Aimee E. Houlton

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.

A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.

Journal: Hematological oncology

Published: June 15, 2019

PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.

PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.

Journal: Archives of disease in childhood

Published: October 02, 2017

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.

Journal: Blood

Published: May 24, 2017

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 22, 2017

Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study.

Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 24, 2015

The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis.

The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis.

Journal: Systematic reviews

Published: July 31, 2015

Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia.

Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia.

Journal: Leukemia

Published: November 27, 2014

Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.

Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 03, 2014

Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.

Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: August 12, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026